Intarcia Therapeutics (United States)
Intarcia Therapeutics is an American biopharmaceutical company based in Boston, MA and incorporated under the laws of Delaware. It was founded in 1995 under the name "BioMedicines" and changed to its present name in 2004. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Intarcia Therapeutics (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
59%
Total
Publications
96
Total Open
Publications
57
Total
Citations
4.5K
Open Access
Percentage
59%
Total
Publications
96
Total Open
Publications
57
Total
Citations
4.5K
Breakdown
Publisher Open
20%
Both
23%
Other Platform Open
15%
Closed
42%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 32%
13
Hybrid 28%
11
No Guarantees 40%
16
Other Platform Open
Domain 83%
29
Preprint 20%
7
Institution 11%
4
Other Internet 3%
1
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 29 |
bioRxiv | Preprint | 7 |
Royal Netherlands Academy of Arts and Sciences | Institution | 3 |
Office of Scientific and Technical Information | Institution | 2 |
Europe PMC | Domain | 2 |
Imperial College London | Institution | 1 |
DOI | Other Internet | 1 |